All In MedTech

Device Trial Radar · NCT05965713

Fully Remote Use of IpsiHand Device in Hemiparetic Stroke

IpsiHand Device Use in Hemiparetic Stroke Population to Assess Home Based EEG System Candidacy for BCI Rehabilitation of the Upper Extremity and the Efficacy of a Full Remote Home Based BCI Therapy - A Randomized Control Trial

Last checked: Nov 19, 2026Latest source record: Nov 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 109 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

109

Actual

Start

Oct 1, 2023

Primary completion

Sep 12, 2025

Study completion Oct 30, 2025

Sponsor

Lead sponsor
Neurolutions, Inc.Not on our public-company list
Sponsor type
Industry
Collaborators
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
First posted
Jul 28, 2023

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

BCI-REHAB was a randomized clinical trial comparing an at-home brain-computer interface therapy system versus an at-home exercise program for upper-extremity rehabilitation in the chronic phases of stroke. The purpose of the trial was to evaluate the efficacy of BCI-based therapy tested against standard exercise therapy and assess the potential for meaningful motor improvement in the home environment.

Conditions

  • Stroke
  • Hemiparesis
  • Spasticity as Sequela of Stroke
  • Brain Computer Interface
  • Chronic Stroke Survivors With Plegic Hand

Interventions

  • Neurolutions IpsiHand Upper Extremity Rehabilitation SystemDevice

    Electroencephalography (EEG)-driven upper extremity powered exerciser. An EEG-driven upper extremity powered exerciser is a non-invasive prescription device intended for rehabilitation by driving movement or exercise of an impaired upper extremity in response to the detection of purpose oriented electrical activity produced by the patient's brain.

  • Home Exercise rehabilitation regimen Program (HEP)Other

    The program consisted of a customized set of range of motion and functional tasks targeting the hand, wrist, elbow, and shoulder. Participants were instructed to complete 1 hour of home exercise per day, 5 days per week, over the course of 12 weeks.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Upper Extremity Fugl-Meyer (UEFM)Time frame: 12 weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Washington University in Saint Louis

    St Louis, Missouri

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.